August 21, 2019
Altimmune Announces $3.7 Million in Additional BARDA Funding to Advance NasoShield™ Clinical Development
Media
August 21, 2019
BONESUPPORT HOLDING AB (publ) announces that the patient enrolment schedule for the ongoing FORTIFY study is extended
August 20, 2019
Orexo signs partnership agreement with GAIA to develop and commercialize a new digital therapy for the treatment of Opioid Use Disorder
August 20, 2019
Oncopeptides appoints Klaas Bakker as new Chief Medical Officer
August 20, 2019
Nordic Nanovector appoints Dr Lars Nieba as Chief Technology Officer
August 13, 2019
Strongbridge Biopharma Announces Key Leadership Appointments to Support Next Stage of Growth
August 13, 2019
Altimmune Announces Second Quarter 2019 Financial Results and Provides a Business Update
August 12, 2019
Targovax ASA: Announcement of second quarter and first half results 2019
August 05, 2019
Aprea Therapeutics Appoints Scott Coiante as Chief Financial Officer
August 05, 2019
Altimmune to Announce Second Quarter 2019 Financial Results on August 14
